tailieunhanh - Báo cáo y học: "New perspectives on an old disease: proteomics in cancer research"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: New perspectives on an old disease: proteomics in cancer research. | Meeting report New perspectives on an old disease proteomics in cancer research Oriol Gallego and Anne-Claude Gavin Address Structural and Computational Biology Unit EMBL Meyerhofstrasse D-69117 Heidelberg Germany. Correspondence Anne-Claude Gavin. Email gavin@ Published 30 April 2007 Genome Biology 2007 8 303 doi gb-2007-8-4-303 The electronic version of this article is the complete one and can be found online at http 2007 8 4 303 2007 BioMed Central Ltd A report on the American Association for Cancer Research Conference Advances in Proteomics in Cancer Research Amelia Island USA 27 February-2 March 2007. Cancer seems to have afflicted humans throughout recorded history. The earliest descriptions are in Egyptian papyri written between 3000 and 1500 BC. Cancer was named some 2 400 years ago after the Greek word karkinos a crab which Hippocrates thought a tumor resembled. More than two millennia later cancer remains among the leading causes of death in industrialized countries. The name cancer covers an extremely heterogeneous set of diseases with different pathologies prognosis and treatments. In many cases histological or molecular standards for diagnosis and categorization are missing. An American Association for Cancer Research conference in February brought together experts covering diverse facets of proteomics and cancer research with the aim of reviewing progress in the quest for new cancer biomarkers. Raymond DuBois Vanderbilt-Ingram Cancer Center Nashville USA opened the conference with a keynote address in which he emphasized the critical importance of early detection in cancer control and prevention. Most cancer can be effectively treated if detected early. The identification of unique molecular signatures in developing cancers is expected to pave the way toward more tailored and personalized treatments. Plasma as a source of cancer biomarkers Blood plasma has attracted great attention as a potential source of protein .